
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Analytical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis
Ferhan Qureshi, Wayne Hu, Louisa Loh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Ferhan Qureshi, Wayne Hu, Louisa Loh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Showing 3 citing articles:
Targeted plasma proteomic analysis uncovers a high-performance biomarker panel for early diagnosis of gastric cancer
Tong Feng, Minwen Jie, Kai Deng, et al.
Clinica Chimica Acta (2024) Vol. 558, pp. 119675-119675
Open Access | Times Cited: 3
Tong Feng, Minwen Jie, Kai Deng, et al.
Clinica Chimica Acta (2024) Vol. 558, pp. 119675-119675
Open Access | Times Cited: 3
Clinical Validation of a Multi-protein, Serum-based Assay for Disease Activity Assessments in Multiple Sclerosis
Tanuja Chitnis, John Foley, Carolina Ionete, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Tanuja Chitnis, John Foley, Carolina Ionete, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Association between Serum Biomarker Profile and Real-World Evidence of Disability in Multiple Sclerosis
Wen Zhu, Chenyi Chen, Lili Zhang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Wen Zhu, Chenyi Chen, Lili Zhang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2